Bioextrax AB (publ) Return on Equity

Bioextrax AB (publ) (BIOEX.ST) currently reports a ROE of -155.02%. That is below the Healthcare sector average of -75.84%. Use the charts on this page to explore Bioextrax AB (publ)'s ROE history and peer comparisons.

Bioextrax AB (publ)'s ROE of -155.02% is lower than the Healthcare sector average of -75.84%. That is roughly 104.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Bioextrax AB (publ)'s current -155.02% should be judged against Healthcare norms (sector average: -75.84%) and against BIOEX.ST's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -155.02%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Bioextrax AB (publ), and consider following BIOEX.ST for alerts when major investors trade the stock.

Bioextrax AB (publ) is classified in the Healthcare sector. On ROE, it currently shows -155.02% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIOEX.ST with unrelated industries.